Photo credit: BioNTech

UBC-grown biotech companies lead global pandemic efforts

Posted on

Millions of Canadians have received the Pfizer-BioNTech COVID-19 vaccine, but what many may not realize is that a key component of the injection was developed right here at UBC.

Acuitas Therapeutics, a UBC spin-off company co-founded by Dr. Pieter Cullis, developed the lipid nanoparticle technology that allows the Pfizer-BioNTech mRNA vaccine to enter human cells….

https://news.ubc.ca/2021/04/26/ubc-grown-biotech-companies-lead-global-pandemic-efforts

 

Read More Impact Stories

Posted on
What if you could charge your electric vehicle in the same amount of time it takes to fill a tank [...]
Posted on
University of Waterloo engineers use AI to advance cancer treatment monitoring Engineers from the University of Waterloo are harnessing artificial [...]
Posted on
The findings could lead to a better understanding of the role played by proteins in disease and the development of [...]